Showing results (101-110 of 841) with videos related to

Sort By:
Pageof 85
American Journal of Respiratory and Critical Care Medicine|August 1, 2019
Nintedanib and Sildenafil in Patients with Idiopathic Pulmonary Fibrosis and Right Heart Dysfunction. A Prespecified Subgroup Analysis of a Double-Blind Randomized Clinical Trial (INSTAGE)Jürgen Behr, Martin Kolb, Jin Woo Song, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|September 17, 2008
Smoking-related interstitial lung disease: radiologic-clinical-pathologic correlationAnil K Attili, Ella A Kazerooni, Barry H Gross, et al.
The European Respiratory Journal|January 26, 2023
Idiopathic pulmonary fibrosis: state of the art for 2023Anna J Podolanczuk, Carey C Thomson, Martine Remy-Jardin, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 6, 2020
Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE StudiesFernando J Martinez, Klaus F Rabe, Brian J Lipworth, et al.
Chest|June 7, 2007
Spirometry utilization for COPD: how do we measure up?Meilan K Han, Min Gayles Kim, Russell Mardon, et al.
Gastroenterology|May 5, 2009
Delayed radionucleotide gastric emptying studies predict morbidity in diabetics with symptoms of gastroparesisBrian Hyett, Fernando J Martinez, Brian M Gill, et al.
AJR. American Journal of Roentgenology|September 23, 2008
Accuracy of high-resolution CT in the diagnosis of diffuse lung disease: effect of predominance and distribution of findingsBaskaran Sundaram, Barry H Gross, Fernando J Martinez, et al.
Lancet (London, England)|September 1, 2009
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trialsPeter M A Calverley, Klaus F Rabe, Udo-Michael Goehring, et al.
Lancet (London, England)|February 17, 2015
Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trialFernando J Martinez, Peter M A Calverley, Udo-Michael Goehring, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 5, 2021
Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis of KRONOSFernando J Martinez, Gary T Ferguson, Eric Bourne, et al.
Pageof 85